Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00774943 · ClinicalTrials.gov registry record · Phase 1
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Phase 1 study, sponsored by Amgen.
- Completed
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
NCT00774943 is a Phase 1 study that has completed, run by Amgen. The registered enrollment target is 58 participants.
The verdict
NCT00774943, a Phase 1 study, has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
This is a Phase 1, randomized, placebo-controlled, double-blind, dose-escalation study of repeat SC doses of AMG 557 in adults with Systemic Lupus Erythematosus.
Interventions
- DRUG AMG 557
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00774943
The ClinicalTrials.gov registry entry for NCT00774943 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AMG 557 is the first listed.
NCT00774943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00774943 about?
NCT00774943 is a clinical study titled "A Study of AMG 557 in Adults With Systemic Lupus Erythematosus". This is a Phase 1, randomized, placebo-controlled, double-blind, dose-escalation study of repeat SC doses of AMG 557 in adults with Systemic Lupus Erythematosus.
What is the current status of trial NCT00774943?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2008-12. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00774943?
The interventions under investigation include: AMG 557 (DRUG).
Who is sponsoring clinical trial NCT00774943?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.